Glickman Mark Ainsider trades

In SEC Form 4 filings, Glickman Mark A is listed as Director of BioStem Technologies, Inc. (BSEM). Glickman Mark A reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 28.

Companies and roles

Company	Role	Transactions	Last filed
BSEMBioStem Technologies, Inc.	Director	2	Aug 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
BSEMBioStem Technologies, Inc.	Aug 27	Aug 28	M	7,671	$0.00	$0	7,671	No	Form 4
BSEMBioStem Technologies, Inc.	Aug 27	Aug 28	M · derivative	7,671	$0.00	$0	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.